Regional cerebral blood flow difference between dementia with Lewy bodies and AD

被引：120

作者：

Ishii, K

Yamaji, S

Kitagaki, H

Imamura, T

Hirono, N

Mori, E

机构：

[1] Hyogo Inst Aging Brain & Cognit Disorders, Div Imaging Res, Himeji, Hyogo 6700981, Japan

[2] Hyogo Inst Aging Brain & Cognit Disorders, Div Clin Neurosci, Himeji, Hyogo 6700981, Japan

来源：

NEUROLOGY | 1999年 / 53卷 / 02期

关键词：

D O I：

10.1212/WNL.53.2.413

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The authors studied 14 patients with dementia with Lewy bodies (DLB), 14 patients with AD, and 14 healthy control subjects with N-isopropyl-p-[I-123]iodoamphetamine SPECT. Comparison with the statistical parametric mappings revealed that relative cerebral blood flow was lower in the occipital lobes and higher in the right medial temporal lobe in the DLB group than in the AD group. Decreased occipital perfusion and relatively well preserved medial temporal perfusion are features that distinguish DLB from AD.

引用

收藏

页码：413 / 416

页数：4

相关论文

共 10 条

[1] Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease [J].

Albin, RL ;

Minoshima, S ;

DAmato, CJ ;

Frey, KA ;

Kuhl, DA ;

Sima, AAF .

NEUROLOGY, 1996, 47 (02) :462-466

[2]

BORGHT VT, 1997, J NUCL MED, V38, P797

[3]

Donnemiller E, 1997, EUR J NUCL MED, V24, P320

[4] Spatial registration and normalization of images [J].

Friston, KJ ;

Ashburner, J ;

Frith, CD ;

Poline, JB ;

Heather, JD ;

Frackowiak, RSJ .

HUMAN BRAIN MAPPING, 1995, 3 (03) :165-189

[5] Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: a comparative study using positron emission tomography [J].

Imamura, T ;

Ishii, K ;

Sasaki, M ;

Kitagaki, H ;

Yamaji, S ;

Hirono, N ;

Shimomura, T ;

Hashimoto, M ;

Tanimukai, S ;

Kazui, H ;

Mori, E .

NEUROSCIENCE LETTERS, 1997, 235 (1-2) :49-52

[6] Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease [J].

Ishii, K ;

Imamura, T ;

Sasaki, M ;

Yamaji, S ;

Sakamoto, S ;

Kitagaki, H ;

Hashimoto, M ;

Hirono, N ;

Shimomura, T ;

Mori, E .

NEUROLOGY, 1998, 51 (01) :125-130

[7] In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease [J].

Kuhl, DE ;

Minoshima, S ;

Fessler, JA ;

Frey, KA ;

Foster, NL ;

Ficaro, EP ;

Wieland, DM ;

Koeppe, RA .

ANNALS OF NEUROLOGY, 1996, 40 (03) :399-410

[8] Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop [J].

McKeith, IG ;

Galasko, D ;

Kosaka, K ;

Perry, EK ;

Dickson, DW ;

Hansen, LA ;

Salmon, DP ;

Lowe, J ;

MIrra, SS ;

Byrne, EJ ;

Lennox, G ;

Quinn, NP ;

Edwardson, JA ;

Ince, PG ;

Bergeron, C ;

Burns, A ;

Miller, BL ;

Lovestone, S ;

Collerton, D ;

Jansen, ENH ;

Ballard, C ;

deVos, RAI ;

Wilcock, GK ;

Jellinger, KA ;

Perry, RH .

NEUROLOGY, 1996, 47 (05) :1113-1124

[9] A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia? [J].

Talbot, PR ;

Lloyd, JJ ;

Snowden, JS ;

Neary, D ;

Testa, HJ .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (03) :306-313

[10] A Tc-99m-HMPAO single-photon emission computed tomography study of Lewy body disease [J].

Varma, AR ;

Talbot, PR ;

Snowden, JS ;

Lloyd, JJ ;

Testa, HJ ;

Neary, D .

JOURNAL OF NEUROLOGY, 1997, 244 (06) :349-359